• 首页
  • 关于期刊
    期刊简介
    编委会
    青年编委会
    合作单位
    《药学研究》编辑部
  • 投稿指南
  • 制度与声明
    出版伦理规范
    学术不端声明
    开放获取(OA)声明
    AIGC工具使用声明
  • 期刊订阅
  • 下载中心
  • English
引用本文:王文义,檀兴慧,陈倪济世,李德森,吴水生.胆汁制钩吻总碱抑制结肠癌细胞增殖的作用研究[J].药学研究,2024,43(5):422-427[点击复制]
【打印本页】      【下载PDF全文】   【查看/发表评论】  【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2873次   下载 3228次 本文二维码信息
码上扫一扫!
胆汁制钩吻总碱抑制结肠癌细胞增殖的作用研究
王文义1,檀兴慧2,陈倪济世2,李德森2,吴水生2
字体:加大+|默认|缩小-
(1.福建中医药大学科技创新与转化中心,福建 福州 350122;2.福建中医药大学药学院,福建 福州 350122)
摘要:
目的 探讨胆汁制钩吻总碱(胆钩吻总碱)体外抗肿瘤效果,旨在为钩吻减毒后存效的研究提供科学依据。方法 通过CCK-8检测观察胆钩吻总碱对人结肠HCT-116细胞、人神经胶质瘤U87细胞、人肝癌HepG2细胞、人肺癌A549细胞的增殖作用,进一步以结肠癌HCT-116为研究对象,以不同浓度胆钩吻总碱(50、100、200 μg•mL-1)干预HCT-116细胞,通过流式细胞技术检测其对细胞周期阻滞的影响;Annexin V FITC/PI流式细胞术检测HCT-116细胞凋亡情况;进一步从蛋白水平检测凋亡相关蛋白表达。结果 在钩吻总生物碱IC50浓度下,胆钩吻总碱对U87、A549、HepG2、HCT-116肿瘤细胞的增殖抑制率均高于钩吻总生物碱组,并且各组之间的差异具有统计学意义(P<0.01)。与空白组相比,不同浓度的胆钩吻总碱处理(50、100、200 μg•mL-1)可有效降低HCT-116细胞的集落形成,并将细胞周期阻滞在G2/M期。胆钩吻总碱还能引发结肠癌HCT-116细胞的晚期凋亡,并对凋亡相关蛋白Bax、Bcl-2、Caspase-3起到调控作用。结论 胆钩吻总碱可以通过调控结肠癌HCT-116细胞周期和凋亡相关蛋白的表达来抑制其增殖。
关键词:  胆汁制钩吻总碱  钩吻总碱  结肠癌  细胞增殖  细胞凋亡
DOI:10.13506/j.cnki.jpr.2024.05.002
基金项目:国家中医药管理局临床中药学高水平中医药重点学科建设项目(No.国中医药人教函〔2023〕85号);福建中医药大学校管科研项目(No.X2021004)
出版日期:2024-05-25
Research on the suppressive effects of alkaloids of bile-processed Gelsemium elegans on colon cancer cell proliferation
WANG Wenyi1,TAN Xinghui2,CHEN Nijishi2,LI Desen2,WU Shuisheng2
(1.Innovation and Transformation Center, Fujian University of Traditional Chinese Medicine Fuzhou 350122,China; 2.College of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350122,China)
Abstract:
Objective To investigate the in vitro anti-tumor effect of the alkaloids of bile-processed Gelsemium elegans (ABPG) and provide scientific basis for the study of the post-detoxification efficacy of Gelsemium elegans(GE). Methods The proliferation effects of BPGA on human colon cancer HCT-116 cells, human glioblastoma U87 cells, human hepatocellular carcinoma HepG2 cells, and human lung adenocarcinoma A549 cells were assessed using CCK-8 assay. Subsequently, focusing on colon cancer HCT-116 cells, different concentrations of BPGA (50, 100, 200 μg•mL-1) were used to intervene with the cells. The influence on cell cycle arrest was determined by flow cytometry. Cell apoptosis was detected using Annexin V FITC/PI flow cytometry assay. Furthermore, investigate apoptosis-related protein expression from a protein level. Results At the IC50 concentration of GE, the proliferation inhibitory rate of ABPG on U87, A549, HepG2, and HCT-116 tumor cells was higher than that of the GE group, and the differences between the groups were statistically significant (P<0.01). Compared with the control group, treatment with different concentrations of BPGA (50, 100, 200 μg•mL-1) effectively reduced colony formation of HCT-116 cells and arrested the cell cycle in the G2/M phase. BPGA also induced late-stage apoptosis in colon cancer HCT-116 cells and regulated apoptosis-related proteins Bax, Bcl-2, and Caspase-3. Conclusion BPGA can suppress the proliferation of colon cancer HCT-116 cells by regulating the expression of cell cycle and apoptosis-related proteins.
Key words:  Alkaloids of bile-processed Gelsemium elegans  Colon cancer  Cell proliferation  Cell apoptosis
今日访问量:2772    总访问量:55339354
网站版权:《药学研究》编辑部     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
主办:山东省食品药品检验研究院、山东省药学会 地址:山东省济南市高新区新泺大街2749号 邮政编码:250101
电话:0531-81216586 电子邮箱:yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
技术支持:北京勤云科技有限公司